Answers are grounded in this paper and cite their sources.
In asthma, inflammatory and structural cells contribute to increased bronchoconstriction acutely and more chronically to airway remodelling. Current asthma therapy doesnt inhibit these features satisfactorily. This review discusses Rho-kinase as a potential drug target, since increasing evidence suggests a central role for this pathway in acute and chronic airway hyperresponsiveness.
No takes yet. Share an insight, caveat, or question.
Gosens et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: